Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs

Parkinson’s disease (PD) affects around ten million people worldwide and is considered the second most prevalent neurodegenerative disease after Alzheimer’s disease. In addition, there is a higher risk incidence in the elderly population. The main PD hallmarks include the loss of dopaminergic neuron...

Full description

Bibliographic Details
Main Authors: Sara Silva, António J. Almeida, Nuno Vale
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/4/508